Tick Bites
8
1
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
The Uninfected Ixodes Scapularis Human Tick Challenge Model
Acquired Tick Resistance in Naturally Exposed Participants
The Tick App: Changing Behaviors With Educational Messaging
Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and Meningoencephalitis
Fever After Tick Bite Study
Tick-borne Illness and Clothing Study
Tick-borne Illness and Clothing Study of Rhode Island
Determining the Complete Protection Time of an Insect Repellent With 30% Citriodiol® Against Three Species of Ticks.